An Interview with Dr. Steven Frank
Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of head and neck oropharyngeal carcinoma (OPC)
Video file
Executive summary
Learn from Dr. Steven Frank as he discusses the results, challenges, and implications of the study "Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of head and neck oropharyngeal carcinoma (OPC)".
Learn More
Key content topics
Top cancer treatments
Guest speakers
Steven
Frank
Radiation Oncologist
MD Anderson
Related contents
Proton Therapy Publication
June 2024
Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT)
Proton Therapy Publication
November 2023
Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial.
Proton Therapy Publication
March 2023
Proton versus photon radiation therapy: A clinical review.
Proton Therapy Publication
August 2022
Proton Beam Therapy for Esophageal Cancer.
Webinar
April 22, 2022
The State of Proton Therapy in the U.S.
James
Metz
Webinar
April 22, 2022
Expanding Proton Therapy to Community Oncology Practices
Barbara
McAneny
Webinar
December 2021
Ongoing Trials and Current Evidence for proton therapy
Daniela
Alterio
Proton Therapy Publication
July 2021
PBT in rectal cancer
Proton Therapy Publication
July 2021
Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.